98.32EUR-0.16%Mkt Cap: 186.37B $P/E: 36.871d ago
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nu…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap186.37B $
Enterprise Value212.74B $
Revenue (TTM)50.64B $
Gross Profit27.18B $
Net Income (TTM)7.09B $
Revenue/Share29.08 USD
Last Price98.32 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees122.0K
CountryDE
SectorHealthcare
IndustryMedical Devices
ISINUS0028241000
Valuation
P/E (Trailing)36.87
P/E (Forward)—
PEG2.24
EV/EBITDA16.75
EV/Revenue4.20
P/S3.61
P/B3.80
EPS (TTM)2.67
EPS (Forward)—
52W Range
95.6486% of range98.76
52W High98.76 EUR
52W Low95.64 EUR
Profitability
Gross Margin56.42%
Oper. Margin14.71%
EBITDA Margin25.07%
Profit Margin14.72%
ROE12.51%
ROA7.52%
Growth
Revenue Growth13.00%
Earnings Growth-47.50%
Cash Flow & Leverage
Operating CF10.40B $
CapEx (TTM)2.36B $
FCF Margin15.48%
FCF Yield4.20%
Net Debt29.47B $
Net Debt/EBITDA2.32
Balance Sheet
Debt/Equity0.27
Current Ratio1.38
Quick Ratio0.80
Book Value/Sh25.55 EUR
Cash/Share3.238 EUR
Dividends
Fwd Div Rate2.180 EUR
Trail. Div Rate2.480 EUR
Div. Yield2.29%
5Y Avg Yield1.82%
Payout Ratio78.96%
Ex-Div DateJul 15, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.73B
Float1.72B
Insiders0.50%
Institutions82.06%
Technical
SMA 5085.59 (+14.9%)
SMA 20091.70 (+7.2%)
Beta0.58
S&P 52W Chg20.80%
Avg Vol (30d)515
Avg Vol (10d)808
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—